Moreover, our studies suggest that downregulation of CX3CR1 allows using significantly lower doses of x-ray to achieve the same effects, which may carry a promise of reducing radiation dose and associated toxicities while maintaining the same efficacy in killing tumor cells. The gene discussed is CX3CR1; the disease is neoplasm.